From circadian clocks to non-alcoholic fatty liver disease

Expert Rev Gastroenterol Hepatol. 2019 Nov;13(11):1107-1112. doi: 10.1080/17474124.2019.1684899. Epub 2019 Oct 30.

Abstract

Introduction: The circadian rhythm is an integral regulator of various endocrine processes in the body, including sleep-wake cycles, hormonal regulation, and metabolism. In addition to metabolic, genetic, and environmental factors, a dysregulated circadian rhythm resulting from lifestyle changes has been implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). An accumulating body of evidence also supports strong association between NAFLD and metabolic disorder, the pathogenesis of which is related to periodic fluctuations in hormonal homeostasis. It is clear that endocrine and circadian rhythms are tightly interconnected. Generally, the circadian rhythm regulates flux patterns of physiological functions. The present review will discuss the modulation of bodily processes by the circadian rhythm with specific attention to the regulation of NAFLD by leptin and related hormones.Areas covered: PubMed/MEDLINE was searched for articles related to concomitant occurrence of NAFLD and T2DM between January 1995 and September 2019. Areas covered included epidemiological, physiology and pathophysiology aspects.Expert opinion: NAFLD and NASH are increasingly prevalent and may be largely mitigated with effective lifestyle modification and, potentially, circadian rhythm stabilization. Improved knowledge of the specific pathogenesis of NAFLD in addition to enhanced diagnostic screening tools and prediction of future disease burden is imperative.

Keywords: Circadian clocks; NAFLD; leptin; melatonin; metabolic syndrome.

Publication types

  • Review

MeSH terms

  • Animals
  • Circadian Rhythm Signaling Peptides and Proteins / metabolism
  • Circadian Rhythm*
  • Energy Metabolism*
  • Humans
  • Leptin / metabolism
  • Liver / metabolism*
  • Liver / pathology
  • Liver / physiopathology
  • Metabolic Diseases / epidemiology
  • Metabolic Diseases / metabolism*
  • Metabolic Diseases / pathology
  • Metabolic Diseases / physiopathology
  • Non-alcoholic Fatty Liver Disease / epidemiology
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Non-alcoholic Fatty Liver Disease / physiopathology
  • Risk Factors
  • Signal Transduction

Substances

  • Circadian Rhythm Signaling Peptides and Proteins
  • Leptin